Impact of empiric antibiotic regimen on bowel colonization in neonates with suspected early onset sepsis.
The purpose of this study was to compare the impact of ampicillin and penicillin used for empiric treatment of early onset sepsis (EOS) on initial gut colonization by aerobic and facultative anaerobic microorganisms. A cluster-randomized, two-center, switch-over study was conducted in two paediatric intensive care units in Estonia and included 276 neonates. Rectal swabs were collected twice a week until discharge or day 60. Colonizing microbes were identified on species level and tested for ampicillin resistance (AR). The number of patients colonized with Gram negative microorganisms and Candida spp was similar in both treatment arms but ampicillin resulted in longer colonization duration (CD) of K. pneumonia (p = 0.012), AR Serratia spp (p = 0.012) and Candida spp (p = 0.02) and penicillin in that of AR Acinetobacter spp (p = 0.001). As for Gram positive microorganisms penicillin treatment was associated with a greater number of colonized patients and higher CD of Enterococcus spp and S. aureus but lower ones of S. haemolyticus and S. hominis. Influence of ampicillin and penicillin on initial gut colonization is somewhat different but these differences are of low clinical relevance and should not be a limiting step when choosing between these two antibiotics for the empiric treatment of EOS.
Parm
U
U
Institute of Microbiology, Tartu University, Ravila 19, 50411 Tartu, Estonia. ylleparm@nooruse.ee
Metsvaht
T
T
Sepp
E
E
Ilmoja
M-L
ML
Pisarev
H
H
Pauskar
M
M
Lutsar
I
I
D000667:Ampicillin / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001419:Bacteria / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification*; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification*; D018592:Cross-Over Studies; D004957:Estonia; D005260:Female; D041981:Gastrointestinal Tract / Q000382:microbiology*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010406:Penicillins / Q000008:administration & dosage*; D012007:Rectum / Q000382:microbiology
D000900:Anti-Bacterial Agents; D010406:Penicillins; D000667:Ampicillin
Pediatrics. 2005 Mar;115(3):e262-8
15687417
MMWR Recomm Rep. 2002 Aug 16;51(RR-11):1-22
12211284
J Appl Microbiol. 2003;95(3):471-8
12911694
Acta Paediatr. 2010 May;99(5):665-672
20096030
Arch Dis Child Fetal Neonatal Ed. 1999 May;80(3):F167-73
10212075
Biol Neonate. 2003;84(1):24-30
12890932
Clin Microbiol Infect. 2000 Jan;6(1):53
11168040
J Clin Microbiol. 2004 Nov;42(11):5184-8
15528713
Clin Microbiol Rev. 1997 Oct;10(4):781-91
9336672
BMC Infect Dis. 2007 Sep 16;7:107
17868474
Biol Neonate. 2003;84(4):304-10
14593241
APMIS. 2006 Nov;114(11):812-7
17078863
Antonie Van Leeuwenhoek. 2006 Apr-May;89(3-4):367-71
16779633
Obstet Gynecol. 2002 Sep;100(3):534-9
12220774
Clin Infect Dis. 2001 Jan 15;32(2):220-7
11170911
Am J Clin Nutr. 1999 May;69(5):1035S-1045S
10232646
J Hosp Infect. 2009 Apr;71(4):340-7
19147256
Pediatr Res. 2003 Sep;54(3):393-9
12788986
Lancet Infect Dis. 2001 Sep;1(2):101-14
11871461
Pediatr Res. 2006 Jan;59(1):96-101
16380405
Pediatr Int. 2005 Jun;47(3):267-73
15910449
Lancet. 2000 Mar 18;355(9208):973-8
10768436
J Hosp Infect. 2007 Apr;65(4):292-306
17350726
Acta Paediatr Scand. 1982 Jul;71(4):559-62
7136670
Clin Infect Dis. 2004 Jul 15;39(2):219-26
15307031
J Clin Microbiol. 1992 Jul;30(7):1654-60
1629319
Pediatr Infect Dis J. 2005 Jul;24(7):635-9
15999007
Clin Nutr. 2006 Jun;25(3):361-8
16677741
Lancet Infect Dis. 2004 May;4(5):278-86
15120344
Microbiol Res. 2009;164(4):404-10
17475456
Pediatr Infect Dis J. 2007 Dec;26(12):1153-6
18043457
Am J Infect Control. 2007 May;35(4):222-30
17482993
Infection. 2002 Jun;30(3):158-60
12120942
Mem Inst Oswaldo Cruz. 2007 Feb;102(1):29-33
17293995
J Hosp Infect. 2009 Apr;71(4):365-70
19216000
Epidemiol Mikrobiol Imunol. 2000 Apr;49(2):51-8
10838776
Pediatrics. 2008 Apr;121(4):689-96
18381532